Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors
Areteia Therapeutics, Inc. (“Areteia”) today announced the appointment of Daniel Becker to the Areteia Board of Directors, effective immediately.
- Areteia Therapeutics, Inc. (“Areteia”) today announced the appointment of Daniel Becker to the Areteia Board of Directors, effective immediately.
- Dr. Becker will serve as a member of the audit committee of the board.
- View the full release here: https://www.businesswire.com/news/home/20240215803782/en/
“I am excited that Dan has been appointed to our board,” said Jorge Bartolome, President and Chief Executive Officer of Areteia. - and Ph.D. (Cellular and Molecular Biology) degrees from the University of Michigan and received his B.S.